[Insulin suppository in the treatment of diabetic patients].
Murakami
M
M
Department of Biopharmaceutics, Kyoto Pharmaceutical University.
Muranishi
S
S
D000277:Adjuvants, Pharmaceutic; D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008041:Linoleic Acids; D051381:Rats; D012459:Salicylates; D013488:Suppositories; D013501:Surface-Active Agents
D000277:Adjuvants, Pharmaceutic; D007328:Insulin; D008041:Linoleic Acids; D012459:Salicylates; D013488:Suppositories; D013501:Surface-Active Agents